GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]

 ITAV_HUMAN              Reviewed;        1048 AA.
P06756; A0AV67; B0LPF4; B7Z883; B7ZLX0; D3DPG8; E7EWZ6; Q53SK4;
Q59EB7; Q6LD15;
01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
03-APR-2007, sequence version 2.
08-MAY-2019, entry version 230.
RecName: Full=Integrin alpha-V;
AltName: Full=Vitronectin receptor {ECO:0000312|HGNC:HGNC:6150};
AltName: Full=Vitronectin receptor subunit alpha;
AltName: CD_antigen=CD51;
Contains:
RecName: Full=Integrin alpha-V heavy chain;
Contains:
RecName: Full=Integrin alpha-V light chain;
Flags: Precursor;
Name=ITGAV {ECO:0000312|HGNC:HGNC:6150};
Synonyms=MSK8 {ECO:0000312|HGNC:HGNC:6150},
VNRA {ECO:0000312|HGNC:HGNC:6150}, VTNR {ECO:0000312|HGNC:HGNC:6150};
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ILE-783.
PubMed=2443500;
Suzuki S., Argraves W.S., Arai H., Languino L.R., Pierschbacher M.D.,
Ruoslahti E.;
"Amino acid sequence of the vitronectin receptor alpha subunit and
comparative expression of adhesion receptor mRNAs.";
J. Biol. Chem. 262:14080-14085(1987).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=10965141;
Sims M.A., Field S., Barnes M.R., Shaikh N., Ellington K.,
Murphy K.E., Spurr N.K., Campbell D.A.;
"Cloning and characterisation of ITGAV, the genomic sequence for human
cell adhesion protein (vitronectin) receptor alpha subunit, CD51.";
Cytogenet. Cell Genet. 89:268-271(2000).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
ILE-783.
TISSUE=Testis;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
ILE-783.
TISSUE=Aortic endothelium;
Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
Ohara O., Nagase T., Kikuno R.F.;
Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15815621; DOI=10.1038/nature03466;
Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
Waterston R.H., Wilson R.K.;
"Generation and annotation of the DNA sequences of human chromosomes 2
and 4.";
Nature 434:724-731(2005).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ILE-783.
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ILE-783.
NHLBI resequencing and genotyping service (RS&G);
Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
[8]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
ILE-783.
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[9]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-62.
PubMed=7522056; DOI=10.1016/0167-4781(94)90278-X;
Donahue J.P., Sugg N., Hawiger J.;
"The integrin alpha v gene: identification and characterization of the
promoter region.";
Biochim. Biophys. Acta 1219:228-232(1994).
[10]
NUCLEOTIDE SEQUENCE [MRNA] OF 413-1048, AND VARIANT ILE-783.
PubMed=2430295; DOI=10.1073/pnas.83.22.8614;
Suzuki S., Argraves W.S., Pytela R., Arai H., Krusius T.,
Pierschbacher M.D., Ruoslahti E.;
"cDNA and amino acid sequences of the cell adhesion protein receptor
recognizing vitronectin reveal a transmembrane domain and homologies
with other adhesion protein receptors.";
Proc. Natl. Acad. Sci. U.S.A. 83:8614-8618(1986).
[11]
PROTEIN SEQUENCE OF 31-41.
PubMed=2467745; DOI=10.1016/0092-8674(89)90172-4;
Cheresh D.A., Smith J.W., Cooper H.M., Quaranta V.;
"A novel vitronectin receptor integrin (alpha v beta x) is responsible
for distinct adhesive properties of carcinoma cells.";
Cell 57:59-69(1989).
[12]
FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH COXSACKIEVIRUS A9
CAPSID PROTEINS.
PubMed=7519807; DOI=10.1006/viro.1994.1494;
Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T.,
Heino J., Hyypiae T.;
"Entry of coxsackievirus A9 into host cells: specific interactions
with alpha v beta 3 integrin, the vitronectin receptor.";
Virology 203:357-365(1994).
[13]
INTERACTION WITH COXSACKIEVIRUS B1 CAPSID PROTEINS.
PubMed=9426447; DOI=10.1006/viro.1997.8831;
Agrez M.V., Shafren D.R., Gu X., Cox K., Sheppard D., Barry R.D.;
"Integrin alpha v beta 6 enhances coxsackievirus B1 lytic infection of
human colon cancer cells.";
Virology 239:71-77(1997).
[14]
INTERACTION WITH HIV-1 TAT.
PubMed=10397733;
Barillari G., Sgadari C., Fiorelli V., Samaniego F., Colombini S.,
Manzari V., Modesti A., Nair B.C., Cafaro A., Stuerzl M., Ensoli B.;
"The Tat protein of human immunodeficiency virus type-1 promotes
vascular cell growth and locomotion by engaging the alpha5beta1 and
alphavbeta3 integrins and by mobilizing sequestered basic fibroblast
growth factor.";
Blood 94:663-672(1999).
[15]
FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN
PARECHOVIRUS 1 CAPSID PROTEINS.
PubMed=11160695; DOI=10.1128/JVI.75.4.1958-1967.2001;
Joki-Korpela P., Marjomaki V., Krogerus C., Heino J., Hyypia T.;
"Entry of human parechovirus 1.";
J. Virol. 75:1958-1967(2001).
[16]
INTERACTION WITH CCN3.
PubMed=12695522; DOI=10.1074/jbc.M302028200;
Lin C.G., Leu S.J., Chen N., Tebeau C.M., Lin S.X., Yeung C.Y.,
Lau L.F.;
"CCN3 (NOV) is a novel angiogenic regulator of the CCN protein
family.";
J. Biol. Chem. 278:24200-24208(2003).
[17]
FUNCTION, AND INTERACTION WITH FBN1.
PubMed=12807887; DOI=10.1074/jbc.M303159200;
Bax D.V., Bernard S.E., Lomas A., Morgan A., Humphries J.,
Shuttleworth C.A., Humphries M.J., Kielty C.M.;
"Cell adhesion to fibrillin-1 molecules and microfibrils is mediated
by alpha 5 beta 1 and alpha v beta 3 integrins.";
J. Biol. Chem. 278:34605-34616(2003).
[18]
GLYCOSYLATION AT ASN-615.
PubMed=12754519; DOI=10.1038/nbt827;
Zhang H., Li X.-J., Martin D.B., Aebersold R.;
"Identification and quantification of N-linked glycoproteins using
hydrazide chemistry, stable isotope labeling and mass spectrometry.";
Nat. Biotechnol. 21:660-666(2003).
[19]
DISULFIDE BONDS.
PubMed=14596610; DOI=10.1021/bi034726u;
Krokhin O.V., Cheng K., Sousa S.L., Ens W., Standing K.G.,
Wilkins J.A.;
"Mass spectrometric based mapping of the disulfide bonding patterns of
integrin alpha chains.";
Biochemistry 42:12950-12959(2003).
[20]
FUNCTION.
PubMed=15184403; DOI=10.1083/jcb.200312172;
Annes J.P., Chen Y., Munger J.S., Rifkin D.B.;
"Integrin alphaVbeta6-mediated activation of latent TGF-beta requires
the latent TGF-beta binding protein-1.";
J. Cell Biol. 165:723-734(2004).
[21]
INTERACTION WITH COXSACKIEVIRUS A9 CAPSID PROTEINS.
PubMed=15194773; DOI=10.1128/JVI.78.13.6967-6973.2004;
Williams C.H., Kajander T., Hyypia T., Jackson T., Sheppard D.,
Stanway G.;
"Integrin alpha v beta 6 is an RGD-dependent receptor for
coxsackievirus A9.";
J. Virol. 78:6967-6973(2004).
[22]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in
signaling networks.";
Cell 127:635-648(2006).
[23]
INTERACTION WITH ADGRA2.
PubMed=16982628; DOI=10.1074/jbc.M605291200;
Vallon M., Essler M.;
"Proteolytically processed soluble tumor endothelial marker (TEM) 5
mediates endothelial cell survival during angiogenesis by linking
integrin alpha(v)beta3 to glycosaminoglycans.";
J. Biol. Chem. 281:34179-34188(2006).
[24]
INTERACTION WITH RAB25.
PubMed=17925226; DOI=10.1016/j.devcel.2007.08.012;
Caswell P.T., Spence H.J., Parsons M., White D.P., Clark K.,
Cheng K.W., Mills G.B., Humphries M.J., Messent A.J., Anderson K.I.,
McCaffrey M.W., Ozanne B.W., Norman J.C.;
"Rab25 associates with alpha5beta1 integrin to promote invasive
migration in 3D microenvironments.";
Dev. Cell 13:496-510(2007).
[25]
FUNCTION, INTERACTION WITH FBN1, AND SUBCELLULAR LOCATION.
PubMed=17158881; DOI=10.1074/jbc.M607008200;
Jovanovic J., Takagi J., Choulier L., Abrescia N.G., Stuart D.I.,
van der Merwe P.A., Mardon H.J., Handford P.A.;
"alphaVbeta6 is a novel receptor for human fibrillin-1. Comparative
studies of molecular determinants underlying integrin-rgd affinity and
specificity.";
J. Biol. Chem. 282:6743-6751(2007).
[26]
FUNCTION, BINDING TO FGF1, AND IDENTIFICATION IN A COMPLEX WITH FGF1
AND FGFR1.
PubMed=18441324; DOI=10.1074/jbc.M801213200;
Mori S., Wu C.Y., Yamaji S., Saegusa J., Shi B., Ma Z., Kuwabara Y.,
Lam K.S., Isseroff R.R., Takada Y.K., Takada Y.;
"Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1
signaling.";
J. Biol. Chem. 283:18066-18075(2008).
[27]
FUNCTION.
PubMed=18635536; DOI=10.1074/jbc.M804835200;
Saegusa J., Akakura N., Wu C.Y., Hoogland C., Ma Z., Lam K.S.,
Liu F.T., Takada Y.K., Takada Y.;
"Pro-inflammatory secretory phospholipase A2 type IIA binds to
integrins alphavbeta3 and alpha4beta1 and induces proliferation of
monocytic cells in an integrin-dependent manner.";
J. Biol. Chem. 283:26107-26115(2008).
[28]
INTERACTION WITH HHV-8 GLYCOPROTEIN B.
PubMed=18045938; DOI=10.1128/JVI.01673-07;
Garrigues H.J., Rubinchikova Y.E., Dipersio C.M., Rose T.M.;
"Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of
Kaposi's sarcoma-associated herpesvirus and functions as an RGD-
dependent entry receptor.";
J. Virol. 82:1570-1580(2008).
[29]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18669648; DOI=10.1073/pnas.0805139105;
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
Elledge S.J., Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
[30]
INTERACTION WITH PTN.
PubMed=19141530; DOI=10.1096/fj.08-117564;
Mikelis C., Sfaelou E., Koutsioumpa M., Kieffer N., Papadimitriou E.;
"Integrin alpha(v)beta(3) is a pleiotrophin receptor required for
pleiotrophin-induced endothelial cell migration through receptor
protein tyrosine phosphatase beta/zeta.";
FASEB J. 23:1459-1469(2009).
[31]
FUNCTION, BINDING TO IGF1, AND IDENTIFICATION IN A COMPLEX WITH IGF1
AND IGF1R.
PubMed=19578119; DOI=10.1074/jbc.M109.013201;
Saegusa J., Yamaji S., Ieguchi K., Wu C.Y., Lam K.S., Liu F.T.,
Takada Y.K., Takada Y.;
"The direct binding of insulin-like growth factor-1 (IGF-1) to
integrin alphavbeta3 is involved in IGF-1 signaling.";
J. Biol. Chem. 284:24106-24114(2009).
[32]
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-74; ASN-615; ASN-704 AND
ASN-874.
TISSUE=Liver;
PubMed=19159218; DOI=10.1021/pr8008012;
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
"Glycoproteomics analysis of human liver tissue by combination of
multiple enzyme digestion and hydrazide chemistry.";
J. Proteome Res. 8:651-661(2009).
[33]
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-74 AND ASN-874.
TISSUE=Leukemic T-cell;
PubMed=19349973; DOI=10.1038/nbt.1532;
Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
Schiess R., Aebersold R., Watts J.D.;
"Mass-spectrometric identification and relative quantification of N-
linked cell surface glycoproteins.";
Nat. Biotechnol. 27:378-386(2009).
[34]
FUNCTION, BINDING TO NRG1, AND IDENTIFICATION IN A COMPLEX WITH NRG1
AND ERBB3.
PubMed=20682778; DOI=10.1074/jbc.M110.113878;
Ieguchi K., Fujita M., Ma Z., Davari P., Taniguchi Y., Sekiguchi K.,
Wang B., Takada Y.K., Takada Y.;
"Direct binding of the EGF-like domain of neuregulin-1 to integrins
({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB
signaling.";
J. Biol. Chem. 285:31388-31398(2010).
[35]
FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH ADENOVIRUS TYPE C
PENTON PROTEIN.
PubMed=20615244; DOI=10.1186/1743-422X-7-148;
Lyle C., McCormick F.;
"Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-
negative cells.";
Virol. J. 7:148-148(2010).
[36]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=21269460; DOI=10.1186/1752-0509-5-17;
Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
"Initial characterization of the human central proteome.";
BMC Syst. Biol. 5:17-17(2011).
[37]
FUNCTION, BINDING TO CX3CL1, AND IDENTIFICATION IN A COMPLEX WITH
CX3CR1 AND CX3CL1.
PubMed=23125415; DOI=10.4049/jimmunol.1200889;
Fujita M., Takada Y.K., Takada Y.;
"Integrins alphavbeta3 and alpha4beta1 act as coreceptors for
fractalkine, and the integrin-binding defective mutant of fractalkine
is an antagonist of CX3CR1.";
J. Immunol. 189:5809-5819(2012).
[38]
INTERACTION WITH CIB1.
PubMed=24011356; DOI=10.1021/bi400678y;
Freeman T.C. Jr., Black J.L., Bray H.G., Dagliyan O., Wu Y.I.,
Tripathy A., Dokholyan N.V., Leisner T.M., Parise L.V.;
"Identification of novel integrin binding partners for calcium and
integrin binding protein 1 (CIB1): structural and thermodynamic basis
of CIB1 promiscuity.";
Biochemistry 52:7082-7090(2013).
[39]
FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HERPES SIMPLEX
VIRUS 1 ENVELOPE GLYCOPROTEIN H.
PubMed=24367260; DOI=10.1371/journal.ppat.1003806;
Gianni T., Salvioli S., Chesnokova L.S., Hutt-Fletcher L.M.,
Campadelli-Fiume G.;
"alphavbeta6- and alphavbeta8-integrins serve as interchangeable
receptors for HSV gH/gL to promote endocytosis and activation of
membrane fusion.";
PLoS Pathog. 9:E1003806-E1003806(2013).
[40]
FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH WEST NILE VIRUS
ENVELOPE PROTEIN E.
PubMed=23658209; DOI=10.1099/vir.0.052613-0;
Schmidt K., Keller M., Bader B.L., Korytar T., Finke S., Ziegler U.,
Groschup M.H.;
"Integrins modulate the infection efficiency of West Nile virus into
cells.";
J. Gen. Virol. 94:1723-1733(2013).
[41]
FUNCTION, AND INTERACTION WITH TGFB1.
PubMed=22278742; DOI=10.1091/mbc.E11-12-1018;
Wang R., Zhu J., Dong X., Shi M., Lu C., Springer T.A.;
"GARP regulates the bioavailability and activation of TGFbeta.";
Mol. Biol. Cell 23:1129-1139(2012).
[42]
FUNCTION.
PubMed=25398877; DOI=10.1074/jbc.M114.579946;
Fujita M., Zhu K., Fujita C.K., Zhao M., Lam K.S., Kurth M.J.,
Takada Y.K., Takada Y.;
"Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces
integrin activation through direct binding to a newly identified
binding site (site 2) in integrins alphavbeta3, alpha4beta1, and
alpha5beta1.";
J. Biol. Chem. 290:259-271(2015).
[43]
INTERACTION WITH CD9; CD81 AND CD151.
PubMed=27993971; DOI=10.1042/BCJ20160998;
Yu J., Lee C.Y., Changou C.A., Cedano-Prieto D.M., Takada Y.K.,
Takada Y.;
"The CD9, CD81, and CD151 EC2 domains bind to the classical RGD-
binding site of integrin alphavbeta3.";
Biochem. J. 474:589-596(2017).
[44]
FUNCTION, AND INTERACTION WITH FGF2.
PubMed=28302677; DOI=10.1042/BSR20170173;
Mori S., Hatori N., Kawaguchi N., Hamada Y., Shih T.C., Wu C.Y.,
Lam K.S., Matsuura N., Yamamoto H., Takada Y.K., Takada Y.;
"The integrin-binding defective FGF2 mutants potently suppress FGF2
signalling and angiogenesis.";
Biosci. Rep. 37:0-0(2017).
[45]
FUNCTION, AND INTERACTION WITH IL1B.
PubMed=29030430; DOI=10.1074/jbc.M117.818302;
Takada Y.K., Yu J., Fujita M., Saegusa J., Wu C.Y., Takada Y.;
"Direct binding to integrins and loss of disulfide linkage in
interleukin-1beta (IL-1beta) are involved in the agonistic action of
IL-1beta.";
J. Biol. Chem. 292:20067-20075(2017).
[46]
FUNCTION, AND INTERACTION WITH IGF2.
PubMed=28873464; DOI=10.1371/journal.pone.0184285;
Cedano Prieto D.M., Cheng Y., Chang C.C., Yu J., Takada Y.K.,
Takada Y.;
"Direct integrin binding to insulin-like growth factor-2 through the
C-domain is required for insulin-like growth factor receptor type 1
(IGF1R) signaling.";
PLoS ONE 12:E0184285-E0184285(2017).
[47]
X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 31-987.
PubMed=11546839; DOI=10.1126/science.1064535;
Xiong J.P., Stehle T., Diefenbach B., Zhang R., Dunker R., Scott D.L.,
Joachimiak A., Goodman S.L., Arnaout M.A.;
"Crystal structure of the extracellular segment of integrin alpha
Vbeta3.";
Science 294:339-345(2001).
[48] {ECO:0000244|PDB:5FFG, ECO:0000244|PDB:5FFO}
X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 31-627 IN COMPLEX WITH TGFB1
AND ITGB6, CALCIUM-BINDING, FUNCTION, SUBUNIT, DISULFIDE BONDS, AND
GLYCOSYLATION AT ASN-74; ASN-290; ASN-296; ASN-488; ASN-554 AND
ASN-615.
PubMed=28117447; DOI=10.1038/nature21035;
Dong X., Zhao B., Iacob R.E., Zhu J., Koksal A.C., Lu C., Engen J.R.,
Springer T.A.;
"Force interacts with macromolecular structure in activation of TGF-
beta.";
Nature 542:55-59(2017).
-!- FUNCTION: The alpha-V (ITGAV) integrins are receptors for
vitronectin, cytotactin, fibronectin, fibrinogen, laminin, matrix
metalloproteinase-2, osteopontin, osteomodulin, prothrombin,
thrombospondin and vWF. They recognize the sequence R-G-D in a
wide array of ligands. ITGAV:ITGB3 binds to fractalkine (CX3CL1)
and may act as its coreceptor in CX3CR1-dependent fractalkine
signaling (PubMed:23125415). ITGAV:ITGB3 binds to NRG1 (via EGF
domain) and this binding is essential for NRG1-ERBB signaling
(PubMed:20682778). ITGAV:ITGB3 binds to FGF1 and this binding is
essential for FGF1 signaling (PubMed:18441324). ITGAV:ITGB3 binds
to FGF2 and this binding is essential for FGF2 signaling
(PubMed:28302677). ITGAV:ITGB3 binds to IGF1 and this binding is
essential for IGF1 signaling (PubMed:19578119). ITGAV:ITGB3 binds
to IGF2 and this binding is essential for IGF2 signaling
(PubMed:28873464). ITGAV:ITGB3 binds to IL1B and this binding is
essential for IL1B signaling (PubMed:29030430). ITGAV:ITGB3 binds
to PLA2G2A via a site (site 2) which is distinct from the
classical ligand-binding site (site 1) and this induces integrin
conformational changes and enhanced ligand binding to site 1
(PubMed:18635536, PubMed:25398877). ITGAV:ITGB3 and ITGAV:ITGB6
act as a receptor for fibrillin-1 (FBN1) and mediate R-G-D-
dependent cell adhesion to FBN1 (PubMed:12807887,
PubMed:17158881). Integrin alpha-V/beta-6 or alpha-V/beta-8
(ITGAV:ITGB6 or ITGAV:ITGB8) mediates R-G-D-dependent release of
transforming growth factor beta-1 (TGF-beta-1) from regulatory
Latency-associated peptide (LAP), thereby playing a key role in
TGF-beta-1 activation (PubMed:15184403, PubMed:22278742,
PubMed:28117447). {ECO:0000269|PubMed:12807887,
ECO:0000269|PubMed:15184403, ECO:0000269|PubMed:17158881,
ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:18635536,
ECO:0000269|PubMed:19578119, ECO:0000269|PubMed:20682778,
ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:23125415,
ECO:0000269|PubMed:25398877, ECO:0000269|PubMed:28117447,
ECO:0000269|PubMed:28302677, ECO:0000269|PubMed:28873464,
ECO:0000269|PubMed:29030430}.
-!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB5 acts as a
receptor for Adenovirus type C. {ECO:0000269|PubMed:20615244}.
-!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB5 and
ITGAV:ITGB3 act as receptors for Coxsackievirus A9 and B1.
{ECO:0000269|PubMed:15194773, ECO:0000269|PubMed:7519807,
ECO:0000269|PubMed:9426447}.
-!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a
receptor for Herpes virus 8/HHV-8. {ECO:0000269|PubMed:18045938}.
-!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB6 acts as a
receptor for herpes simplex 1/HHV-1.
{ECO:0000269|PubMed:24367260}.
-!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a
receptor for Human parechovirus 1. {ECO:0000269|PubMed:11160695}.
-!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a
receptor for West nile virus. {ECO:0000269|PubMed:23658209}.
-!- FUNCTION: (Microbial infection) In case of HIV-1 infection, the
interaction with extracellular viral Tat protein seems to enhance
angiogenesis in Kaposi's sarcoma lesions.
{ECO:0000269|PubMed:10397733}.
-!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
subunit is composed of a heavy and a light chain linked by a
disulfide bond. Alpha-V (ITGAV) associates with either beta-1
(ITGB1), beta-3 (ITGB3), beta-5 (ITGB5), beta-6 (ITGB6) or beta-8
(ITGB8). Interacts with CIB1 (PubMed:24011356). Interacts with
RAB25 (PubMed:17925226). Integrins ITGAV:ITGB3 and ITGAV:ITGB5
interact with FBLN5 (via N-terminus) (By similarity). ITGAV:ITGB3
and ITGAV:ITGB5 interact with CCN3 (PubMed:12695522). ITGAV:ITGB3
interacts with ADGRA2 (PubMed:16982628). ITGAV:ITGB3 interacts
with FGF2; it is likely that FGF2 can simultaneously bind
ITGAV:ITGB3 and FGF receptors (PubMed:28302677). ITGAV:ITGB3
interacts with IL1B (PubMed:29030430). ITGAV:ITGB3 is found in a
ternary complex with CX3CR1 and CX3CL1 (PubMed:23125415).
ITGAV:ITGB3 is found in a ternary complex with NRG1 and ERBB3
(PubMed:20682778). ITGAV:ITGB3 is found in a ternary complex with
FGF1 and FGFR1 (PubMed:18441324). ITGAV:ITGB3 is found in a
ternary complex with IGF1 and IGF1R (PubMed:19578119). ITGAV:ITGB3
interacts with IGF2 (PubMed:28873464). ITGAV:ITGB3 and ITGAV:ITGB6
interact with FBN1 (PubMed:12807887, PubMed:17158881). ITGAV:ITGB3
interacts with CD9, CD81 and CD151 (via second extracellular
domain) (PubMed:27993971). ITGAV:ITGB6 interacts with TGFB1
(PubMed:22278742, PubMed:28117447). ITGAV:ITGB3 interacts with PTN
(PubMed:19141530). Forms a complex with PTPRZ1 and PTN that
stimulates endothelial cell migration through ITGB3 'Tyr-773'
phosphorylation (PubMed:19141530). {ECO:0000250|UniProtKB:P43406,
ECO:0000250|UniProtKB:P80746, ECO:0000269|PubMed:12695522,
ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:16982628,
ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:17925226,
ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:19141530,
ECO:0000269|PubMed:19578119, ECO:0000269|PubMed:20615244,
ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:22278742,
ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:23658209,
ECO:0000269|PubMed:24011356, ECO:0000269|PubMed:27993971,
ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:28302677,
ECO:0000269|PubMed:28873464, ECO:0000269|PubMed:29030430}.
-!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
herpes virus 8/HHV-8 envelope glycoprotein B.
{ECO:0000269|PubMed:18045938}.
-!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 and
ITGAV:ITGB6 bind to coxsackievirus A9 and coxsackievirus B1 capsid
proteins (PubMed:9426447, PubMed:15194773, PubMed:7519807).
{ECO:0000269|PubMed:15194773, ECO:0000269|PubMed:7519807,
ECO:0000269|PubMed:9426447}.
-!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB6 interacts with
herpes simplex 1/HHV-1 envelope glycoprotein H.
{ECO:0000269|PubMed:24367260}.
-!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB5 interacts with
adenovirus type C penton protein. {ECO:0000269|PubMed:20615244}.
-!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
Human parechovirus 1 capsid proteins.
{ECO:0000269|PubMed:11160695}.
-!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
West nile virus envelope protein E. {ECO:0000269|PubMed:23658209}.
-!- SUBUNIT: (Microbial infection) Interacts with HIV-1 Tat.
{ECO:0000269|PubMed:10397733}.
-!- INTERACTION:
P05106:ITGB3; NbExp=13; IntAct=EBI-298282, EBI-702847;
P18084:ITGB5; NbExp=2; IntAct=EBI-298282, EBI-1223434;
P18564:ITGB6; NbExp=7; IntAct=EBI-298282, EBI-2568070;
-!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
protein. Cell junction, focal adhesion
{ECO:0000269|PubMed:17158881}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=3;
Name=1;
IsoId=P06756-1; Sequence=Displayed;
Name=2;
IsoId=P06756-2; Sequence=VSP_024351;
Note=No experimental confirmation available.;
Name=3;
IsoId=P06756-3; Sequence=VSP_044914;
Note=No experimental confirmation available.;
-!- SIMILARITY: Belongs to the integrin alpha chain family.
{ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=BAD93131.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; M14648; AAA36808.1; -; mRNA.
EMBL; AF251841; AAG03000.1; -; Genomic_DNA.
EMBL; AF251818; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251819; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251820; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251821; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251822; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251823; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251824; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251825; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251826; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251827; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251828; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251829; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251830; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251831; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251832; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251833; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251834; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251835; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251836; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251837; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251838; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251839; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AF251840; AAG03000.1; JOINED; Genomic_DNA.
EMBL; AK302990; BAH13869.1; -; mRNA.
EMBL; AB209894; BAD93131.1; ALT_INIT; mRNA.
EMBL; AC017101; AAY24257.1; -; Genomic_DNA.
EMBL; EU332844; ABY87533.1; -; Genomic_DNA.
EMBL; CH471058; EAX10934.1; -; Genomic_DNA.
EMBL; BC126231; AAI26232.1; -; mRNA.
EMBL; BC136442; AAI36443.1; -; mRNA.
EMBL; BC144100; AAI44101.1; -; mRNA.
EMBL; U07375; AAA61631.1; -; Genomic_DNA.
CCDS; CCDS2292.1; -. [P06756-1]
CCDS; CCDS46470.1; -. [P06756-2]
CCDS; CCDS46471.1; -. [P06756-3]
PIR; A27421; A27421.
RefSeq; NP_001138471.1; NM_001144999.2.
RefSeq; NP_001138472.1; NM_001145000.2.
RefSeq; NP_002201.1; NM_002210.4. [P06756-1]
PDB; 1JV2; X-ray; 3.10 A; A=31-987.
PDB; 1L5G; X-ray; 3.20 A; A=31-987.
PDB; 1M1X; X-ray; 3.30 A; A=31-987.
PDB; 1U8C; X-ray; 3.10 A; A=31-987.
PDB; 3IJE; X-ray; 2.90 A; A=31-997.
PDB; 4G1E; X-ray; 3.00 A; A=31-989.
PDB; 4G1M; X-ray; 2.90 A; A=31-989.
PDB; 4MMX; X-ray; 3.32 A; A=31-989.
PDB; 4MMY; X-ray; 3.18 A; A=31-989.
PDB; 4MMZ; X-ray; 3.10 A; A=31-989.
PDB; 4O02; X-ray; 3.60 A; A=31-992.
PDB; 4UM8; X-ray; 2.85 A; A/C=31-625.
PDB; 4UM9; X-ray; 2.50 A; A/C=31-625.
PDB; 5FFG; X-ray; 2.25 A; A=31-625.
PDB; 5FFO; X-ray; 3.49 A; A/E=31-625.
PDB; 5NEM; EM; 3.10 A; A=31-624.
PDB; 5NER; EM; 3.10 A; A=31-624.
PDB; 5NET; EM; 3.10 A; A=31-624.
PDB; 5NEU; EM; 3.10 A; A=31-624.
PDB; 6AVQ; EM; 35.00 A; A=31-987.
PDB; 6AVR; EM; 35.00 A; A=31-987.
PDB; 6AVU; EM; 35.00 A; A=31-987.
PDB; 6DJP; EM; 4.80 A; A=31-995.
PDBsum; 1JV2; -.
PDBsum; 1L5G; -.
PDBsum; 1M1X; -.
PDBsum; 1U8C; -.
PDBsum; 3IJE; -.
PDBsum; 4G1E; -.
PDBsum; 4G1M; -.
PDBsum; 4MMX; -.
PDBsum; 4MMY; -.
PDBsum; 4MMZ; -.
PDBsum; 4O02; -.
PDBsum; 4UM8; -.
PDBsum; 4UM9; -.
PDBsum; 5FFG; -.
PDBsum; 5FFO; -.
PDBsum; 5NEM; -.
PDBsum; 5NER; -.
PDBsum; 5NET; -.
PDBsum; 5NEU; -.
PDBsum; 6AVQ; -.
PDBsum; 6AVR; -.
PDBsum; 6AVU; -.
PDBsum; 6DJP; -.
SMR; P06756; -.
BioGrid; 109891; 75.
ComplexPortal; CPX-1795; Integrin alphav-beta3 complex.
ComplexPortal; CPX-1796; Integrin alphav-beta5 complex.
ComplexPortal; CPX-1819; Integrin alphav-beta1 complex.
ComplexPortal; CPX-1820; Integrin alphav-beta6 complex.
ComplexPortal; CPX-1821; Integrin alphav-beta8 complex.
CORUM; P06756; -.
DIP; DIP-31785N; -.
ELM; P06756; -.
IntAct; P06756; 21.
MINT; P06756; -.
STRING; 9606.ENSP00000261023; -.
BindingDB; P06756; -.
ChEMBL; CHEMBL3660; -.
DrugBank; DB00098; Anti-thymocyte Globulin (Rabbit).
GuidetoPHARMACOLOGY; 2453; -.
TCDB; 8.A.54.1.4; the integrin (integrin) family.
GlyConnect; 1412; -.
iPTMnet; P06756; -.
PhosphoSitePlus; P06756; -.
BioMuta; ITGAV; -.
DMDM; 143811408; -.
EPD; P06756; -.
jPOST; P06756; -.
MaxQB; P06756; -.
PaxDb; P06756; -.
PeptideAtlas; P06756; -.
PRIDE; P06756; -.
ProteomicsDB; 51933; -.
ProteomicsDB; 51934; -. [P06756-2]
Ensembl; ENST00000261023; ENSP00000261023; ENSG00000138448. [P06756-1]
Ensembl; ENST00000374907; ENSP00000364042; ENSG00000138448. [P06756-2]
Ensembl; ENST00000433736; ENSP00000404291; ENSG00000138448. [P06756-3]
GeneID; 3685; -.
KEGG; hsa:3685; -.
UCSC; uc002upq.5; human. [P06756-1]
CTD; 3685; -.
DisGeNET; 3685; -.
GeneCards; ITGAV; -.
HGNC; HGNC:6150; ITGAV.
HPA; CAB002499; -.
HPA; HPA004856; -.
MIM; 193210; gene.
neXtProt; NX_P06756; -.
OpenTargets; ENSG00000138448; -.
PharmGKB; PA37336; -.
eggNOG; ENOG410IPB5; Eukaryota.
eggNOG; ENOG410YR19; LUCA.
GeneTree; ENSGT00940000158361; -.
HOGENOM; HOG000231603; -.
InParanoid; P06756; -.
KO; K06487; -.
OMA; APLYQWS; -.
OrthoDB; 135910at2759; -.
PhylomeDB; P06756; -.
TreeFam; TF105391; -.
Reactome; R-HSA-1236973; Cross-presentation of particulate exogenous antigens (phagosomes).
Reactome; R-HSA-1566948; Elastic fibre formation.
Reactome; R-HSA-210990; PECAM1 interactions.
Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
Reactome; R-HSA-216083; Integrin cell surface interactions.
Reactome; R-HSA-3000157; Laminin interactions.
Reactome; R-HSA-3000170; Syndecan interactions.
Reactome; R-HSA-3000178; ECM proteoglycans.
Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
Reactome; R-HSA-445144; Signal transduction by L1.
Reactome; R-HSA-6798695; Neutrophil degranulation.
SignaLink; P06756; -.
SIGNOR; P06756; -.
ChiTaRS; ITGAV; human.
EvolutionaryTrace; P06756; -.
GeneWiki; ITGAV; -.
GenomeRNAi; 3685; -.
PRO; PR:P06756; -.
Proteomes; UP000005640; Chromosome 2.
Bgee; ENSG00000138448; Expressed in 247 organ(s), highest expression level in pigmented layer of retina.
ExpressionAtlas; P06756; baseline and differential.
Genevisible; P06756; HS.
GO; GO:0035868; C:alphav-beta3 integrin-HMGB1 complex; IDA:BHF-UCL.
GO; GO:0035867; C:alphav-beta3 integrin-IGF-1-IGF1R complex; IDA:BHF-UCL.
GO; GO:0035866; C:alphav-beta3 integrin-PKCalpha complex; NAS:BHF-UCL.
GO; GO:0009986; C:cell surface; IDA:UniProtKB.
GO; GO:0005829; C:cytosol; IDA:HPA.
GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
GO; GO:0031527; C:filopodium membrane; IDA:UniProtKB.
GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
GO; GO:0034683; C:integrin alphav-beta3 complex; IDA:UniProtKB.
GO; GO:0034684; C:integrin alphav-beta5 complex; IDA:UniProtKB.
GO; GO:0034685; C:integrin alphav-beta6 complex; IDA:UniProtKB.
GO; GO:0034686; C:integrin alphav-beta8 complex; IDA:UniProtKB.
GO; GO:0008305; C:integrin complex; IDA:BHF-UCL.
GO; GO:0031258; C:lamellipodium membrane; IDA:UniProtKB.
GO; GO:0016020; C:membrane; ISS:BHF-UCL.
GO; GO:0031528; C:microvillus membrane; IDA:UniProtKB.
GO; GO:0045335; C:phagocytic vesicle; TAS:Reactome.
GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
GO; GO:0032587; C:ruffle membrane; IDA:UniProtKB.
GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
GO; GO:0015026; F:coreceptor activity; TAS:UniProtKB.
GO; GO:0050840; F:extracellular matrix binding; IDA:UniProtKB.
GO; GO:1990430; F:extracellular matrix protein binding; IDA:UniProtKB.
GO; GO:0001968; F:fibronectin binding; IDA:UniProtKB.
GO; GO:0005178; F:integrin binding; IPI:BHF-UCL.
GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
GO; GO:0001846; F:opsonin binding; IEA:Ensembl.
GO; GO:0002020; F:protease binding; IDA:UniProtKB.
GO; GO:0005080; F:protein kinase C binding; IEA:Ensembl.
GO; GO:0050431; F:transforming growth factor beta binding; ISS:BHF-UCL.
GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB.
GO; GO:0001525; P:angiogenesis; IEP:UniProtKB.
GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
GO; GO:0038027; P:apolipoprotein A-I-mediated signaling pathway; IMP:UniProtKB.
GO; GO:0043277; P:apoptotic cell clearance; IGI:BHF-UCL.
GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
GO; GO:0007155; P:cell adhesion; IDA:BHF-UCL.
GO; GO:0033627; P:cell adhesion mediated by integrin; IDA:UniProtKB.
GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
GO; GO:0031589; P:cell-substrate adhesion; IMP:UniProtKB.
GO; GO:0035987; P:endodermal cell differentiation; IMP:UniProtKB.
GO; GO:0052066; P:entry of symbiont into host cell by promotion of host phagocytosis; NAS:BHF-UCL.
GO; GO:0070371; P:ERK1 and ERK2 cascade; ISS:BHF-UCL.
GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISS:BHF-UCL.
GO; GO:0034113; P:heterotypic cell-cell adhesion; IMP:UniProtKB.
GO; GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB.
GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
GO; GO:0050919; P:negative chemotaxis; IMP:UniProtKB.
GO; GO:2000536; P:negative regulation of entry of bacterium into host cell; IDA:BHF-UCL.
GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:BHF-UCL.
GO; GO:0010888; P:negative regulation of lipid storage; IMP:BHF-UCL.
GO; GO:0032369; P:negative regulation of lipid transport; IMP:BHF-UCL.
GO; GO:0050748; P:negative regulation of lipoprotein metabolic process; IMP:BHF-UCL.
GO; GO:0045715; P:negative regulation of low-density lipoprotein particle receptor biosynthetic process; IMP:BHF-UCL.
GO; GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IMP:BHF-UCL.
GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
GO; GO:0045785; P:positive regulation of cell adhesion; IDA:BHF-UCL.
GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:BHF-UCL.
GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
GO; GO:0033690; P:positive regulation of osteoblast proliferation; IEA:Ensembl.
GO; GO:0050764; P:regulation of phagocytosis; IDA:BHF-UCL.
GO; GO:1901388; P:regulation of transforming growth factor beta activation; IDA:UniProtKB.
GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:UniProtKB.
GO; GO:0038044; P:transforming growth factor-beta secretion; IEA:Ensembl.
GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
GO; GO:0001570; P:vasculogenesis; IEA:Ensembl.
GO; GO:0046718; P:viral entry into host cell; IMP:UniProtKB.
Gene3D; 2.130.10.130; -; 1.
InterPro; IPR013517; FG-GAP.
InterPro; IPR013519; Int_alpha_beta-p.
InterPro; IPR000413; Integrin_alpha.
InterPro; IPR013649; Integrin_alpha-2.
InterPro; IPR018184; Integrin_alpha_C_CS.
InterPro; IPR028994; Integrin_alpha_N.
InterPro; IPR032695; Integrin_dom_sf.
Pfam; PF01839; FG-GAP; 3.
Pfam; PF00357; Integrin_alpha; 1.
Pfam; PF08441; Integrin_alpha2; 1.
PRINTS; PR01185; INTEGRINA.
SMART; SM00191; Int_alpha; 5.
SUPFAM; SSF69179; SSF69179; 3.
PROSITE; PS51470; FG_GAP; 7.
PROSITE; PS00242; INTEGRIN_ALPHA; 1.
1: Evidence at protein level;
3D-structure; Alternative splicing; Calcium; Cell adhesion;
Cell junction; Cell membrane; Cleavage on pair of basic residues;
Complete proteome; Direct protein sequencing; Disulfide bond;
Glycoprotein; Host cell receptor for virus entry;
Host-virus interaction; Integrin; Membrane; Metal-binding;
Polymorphism; Receptor; Reference proteome; Repeat; Signal;
Transmembrane; Transmembrane helix.
SIGNAL 1 30 {ECO:0000269|PubMed:2467745}.
CHAIN 31 1048 Integrin alpha-V.
/FTId=PRO_0000016301.
CHAIN 31 889 Integrin alpha-V heavy chain.
/FTId=PRO_0000016302.
CHAIN 891 1048 Integrin alpha-V light chain.
/FTId=PRO_0000016303.
TOPO_DOM 31 992 Extracellular. {ECO:0000255}.
TRANSMEM 993 1016 Helical. {ECO:0000255}.
TOPO_DOM 1017 1048 Cytoplasmic. {ECO:0000255}.
REPEAT 32 98 FG-GAP 1. {ECO:0000255|PROSITE-
ProRule:PRU00803}.
REPEAT 109 170 FG-GAP 2. {ECO:0000255|PROSITE-
ProRule:PRU00803}.
REPEAT 173 225 FG-GAP 3. {ECO:0000255|PROSITE-
ProRule:PRU00803}.
REPEAT 237 291 FG-GAP 4. {ECO:0000255|PROSITE-
ProRule:PRU00803}.
REPEAT 292 357 FG-GAP 5. {ECO:0000255|PROSITE-
ProRule:PRU00803}.
REPEAT 358 415 FG-GAP 6. {ECO:0000255|PROSITE-
ProRule:PRU00803}.
REPEAT 419 482 FG-GAP 7. {ECO:0000255|PROSITE-
ProRule:PRU00803}.
CA_BIND 260 268 {ECO:0000255,
ECO:0000269|PubMed:28117447}.
CA_BIND 314 322 {ECO:0000255,
ECO:0000269|PubMed:28117447}.
CA_BIND 379 387 {ECO:0000255,
ECO:0000269|PubMed:28117447}.
CA_BIND 443 451 {ECO:0000255,
ECO:0000269|PubMed:28117447}.
MOTIF 1019 1023 GFFKR motif.
CARBOHYD 74 74 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:19159218,
ECO:0000269|PubMed:19349973,
ECO:0000269|PubMed:28117447}.
CARBOHYD 290 290 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:28117447}.
CARBOHYD 296 296 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:28117447}.
CARBOHYD 488 488 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:28117447}.
CARBOHYD 554 554 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:28117447}.
CARBOHYD 615 615 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:12754519,
ECO:0000269|PubMed:19159218,
ECO:0000269|PubMed:28117447}.
CARBOHYD 704 704 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:19159218}.
CARBOHYD 835 835 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 851 851 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 874 874 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:19159218,
ECO:0000269|PubMed:19349973}.
CARBOHYD 945 945 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 973 973 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 980 980 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
DISULFID 89 97 {ECO:0000269|PubMed:14596610,
ECO:0000269|PubMed:28117447}.
DISULFID 138 158 {ECO:0000269|PubMed:14596610,
ECO:0000269|PubMed:28117447}.
DISULFID 172 185 {ECO:0000269|PubMed:14596610,
ECO:0000269|PubMed:28117447}.
DISULFID 491 502 {ECO:0000269|PubMed:14596610}.
DISULFID 508 565 {ECO:0000269|PubMed:14596610}.
DISULFID 626 632 {ECO:0000269|PubMed:14596610}.
DISULFID 698 711 {ECO:0000269|PubMed:14596610}.
DISULFID 852 914 Interchain (between heavy and light
chains). {ECO:0000269|PubMed:14596610}.
DISULFID 904 909 {ECO:0000269|PubMed:14596610}.
VAR_SEQ 1 62 MAFPPRRRLRLGPRGLPLLLSGLLLPLCRAFNLDVDSPAEY
SGPEGSYFGFAVDFFVPSASS -> MLLGTLLLILYILMLC
(in isoform 3).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_044914.
VAR_SEQ 175 211 QDIDADGQGFCQGGFSIDFTKADRVLLGGPGSFYWQG ->
R (in isoform 2).
{ECO:0000303|PubMed:15489334,
ECO:0000303|Ref.4}.
/FTId=VSP_024351.
VARIANT 405 405 I -> V (in dbSNP:rs3738918).
/FTId=VAR_024289.
VARIANT 548 548 S -> A (in dbSNP:rs2230615).
/FTId=VAR_055970.
VARIANT 783 783 V -> I (in dbSNP:rs2230616).
{ECO:0000269|PubMed:14702039,
ECO:0000269|PubMed:15489334,
ECO:0000269|PubMed:2430295,
ECO:0000269|PubMed:2443500,
ECO:0000269|Ref.4, ECO:0000269|Ref.6,
ECO:0000269|Ref.7}.
/FTId=VAR_031547.
CONFLICT 425 425 W -> R (in Ref. 2; AAG03000).
{ECO:0000305}.
CONFLICT 700 700 F -> L (in Ref. 8; AAI44101).
{ECO:0000305}.
CONFLICT 1039 1039 H -> R (in Ref. 2; AAG03000).
{ECO:0000305}.
STRAND 39 42 {ECO:0000244|PDB:5FFG}.
TURN 45 50 {ECO:0000244|PDB:5FFG}.
STRAND 51 56 {ECO:0000244|PDB:5FFG}.
STRAND 60 62 {ECO:0000244|PDB:4UM9}.
STRAND 65 70 {ECO:0000244|PDB:5FFG}.
STRAND 85 95 {ECO:0000244|PDB:5FFG}.
STRAND 97 100 {ECO:0000244|PDB:5FFG}.
STRAND 109 111 {ECO:0000244|PDB:5FFG}.
STRAND 114 118 {ECO:0000244|PDB:5FFG}.
STRAND 126 131 {ECO:0000244|PDB:5FFG}.
STRAND 134 139 {ECO:0000244|PDB:5FFG}.
STRAND 147 150 {ECO:0000244|PDB:5FFG}.
STRAND 157 162 {ECO:0000244|PDB:5FFG}.
STRAND 165 169 {ECO:0000244|PDB:5FFG}.
STRAND 174 176 {ECO:0000244|PDB:5FFG}.
TURN 178 184 {ECO:0000244|PDB:5FFG}.
STRAND 189 193 {ECO:0000244|PDB:5FFG}.
STRAND 197 203 {ECO:0000244|PDB:5FFG}.
HELIX 206 209 {ECO:0000244|PDB:5FFG}.
STRAND 211 217 {ECO:0000244|PDB:5FFG}.
HELIX 218 223 {ECO:0000244|PDB:5FFG}.
STRAND 235 239 {ECO:0000244|PDB:4G1E}.
HELIX 245 247 {ECO:0000244|PDB:5FFG}.
STRAND 254 259 {ECO:0000244|PDB:5FFG}.
STRAND 261 266 {ECO:0000244|PDB:5FFG}.
STRAND 268 273 {ECO:0000244|PDB:5FFG}.
HELIX 276 279 {ECO:0000244|PDB:5FFG}.
STRAND 282 286 {ECO:0000244|PDB:5FFG}.
TURN 288 290 {ECO:0000244|PDB:5FFG}.
STRAND 293 298 {ECO:0000244|PDB:5FFG}.
STRAND 308 313 {ECO:0000244|PDB:5FFG}.
STRAND 316 319 {ECO:0000244|PDB:5FFG}.
STRAND 322 327 {ECO:0000244|PDB:5FFG}.
STRAND 331 333 {ECO:0000244|PDB:5FFG}.
STRAND 335 337 {ECO:0000244|PDB:4G1M}.
STRAND 339 341 {ECO:0000244|PDB:5FFG}.
STRAND 344 350 {ECO:0000244|PDB:5FFG}.
STRAND 352 354 {ECO:0000244|PDB:3IJE}.
STRAND 356 362 {ECO:0000244|PDB:5FFG}.
STRAND 364 368 {ECO:0000244|PDB:1JV2}.
HELIX 370 372 {ECO:0000244|PDB:1U8C}.
STRAND 374 378 {ECO:0000244|PDB:5FFG}.
STRAND 383 385 {ECO:0000244|PDB:5FFG}.
STRAND 387 392 {ECO:0000244|PDB:5FFG}.
HELIX 397 399 {ECO:0000244|PDB:5FFG}.
STRAND 402 409 {ECO:0000244|PDB:5FFG}.
STRAND 410 413 {ECO:0000244|PDB:4UM8}.
STRAND 418 422 {ECO:0000244|PDB:5FFG}.
STRAND 428 430 {ECO:0000244|PDB:4UM9}.
STRAND 436 442 {ECO:0000244|PDB:5FFG}.
STRAND 447 449 {ECO:0000244|PDB:5FFG}.
STRAND 451 456 {ECO:0000244|PDB:5FFG}.
HELIX 457 459 {ECO:0000244|PDB:5FFG}.
STRAND 461 465 {ECO:0000244|PDB:5FFG}.
STRAND 470 485 {ECO:0000244|PDB:5FFG}.
STRAND 494 499 {ECO:0000244|PDB:3IJE}.
STRAND 502 512 {ECO:0000244|PDB:5FFG}.
STRAND 514 516 {ECO:0000244|PDB:5FFG}.
STRAND 519 528 {ECO:0000244|PDB:5FFG}.
TURN 529 532 {ECO:0000244|PDB:5FFG}.
STRAND 535 537 {ECO:0000244|PDB:4G1M}.
STRAND 541 543 {ECO:0000244|PDB:5FFG}.
TURN 544 546 {ECO:0000244|PDB:5FFG}.
STRAND 547 558 {ECO:0000244|PDB:5FFG}.
STRAND 559 561 {ECO:0000244|PDB:4MMY}.
STRAND 564 572 {ECO:0000244|PDB:5FFG}.
HELIX 575 577 {ECO:0000244|PDB:5FFG}.
STRAND 585 593 {ECO:0000244|PDB:5FFG}.
TURN 595 597 {ECO:0000244|PDB:4UM9}.
STRAND 601 603 {ECO:0000244|PDB:4G1E}.
STRAND 610 612 {ECO:0000244|PDB:5FFG}.
STRAND 614 623 {ECO:0000244|PDB:5FFG}.
TURN 627 630 {ECO:0000244|PDB:3IJE}.
STRAND 636 641 {ECO:0000244|PDB:3IJE}.
STRAND 646 648 {ECO:0000244|PDB:3IJE}.
STRAND 653 663 {ECO:0000244|PDB:3IJE}.
STRAND 668 670 {ECO:0000244|PDB:3IJE}.
STRAND 672 676 {ECO:0000244|PDB:3IJE}.
STRAND 681 686 {ECO:0000244|PDB:3IJE}.
STRAND 691 693 {ECO:0000244|PDB:4G1E}.
STRAND 697 701 {ECO:0000244|PDB:3IJE}.
STRAND 703 705 {ECO:0000244|PDB:3IJE}.
STRAND 708 712 {ECO:0000244|PDB:3IJE}.
STRAND 715 717 {ECO:0000244|PDB:3IJE}.
STRAND 722 731 {ECO:0000244|PDB:3IJE}.
STRAND 735 737 {ECO:0000244|PDB:4G1E}.
STRAND 739 748 {ECO:0000244|PDB:3IJE}.
STRAND 752 754 {ECO:0000244|PDB:3IJE}.
STRAND 760 767 {ECO:0000244|PDB:3IJE}.
STRAND 772 786 {ECO:0000244|PDB:3IJE}.
TURN 798 802 {ECO:0000244|PDB:3IJE}.
STRAND 805 814 {ECO:0000244|PDB:3IJE}.
STRAND 816 818 {ECO:0000244|PDB:3IJE}.
STRAND 820 833 {ECO:0000244|PDB:3IJE}.
STRAND 839 856 {ECO:0000244|PDB:3IJE}.
STRAND 900 902 {ECO:0000244|PDB:3IJE}.
TURN 904 906 {ECO:0000244|PDB:3IJE}.
STRAND 907 916 {ECO:0000244|PDB:3IJE}.
STRAND 923 933 {ECO:0000244|PDB:3IJE}.
HELIX 935 938 {ECO:0000244|PDB:3IJE}.
STRAND 941 944 {ECO:0000244|PDB:3IJE}.
STRAND 948 960 {ECO:0000244|PDB:3IJE}.
STRAND 964 966 {ECO:0000244|PDB:4G1E}.
STRAND 971 982 {ECO:0000244|PDB:3IJE}.
SEQUENCE 1048 AA; 116038 MW; 364EE25C5303A2D7 CRC64;
MAFPPRRRLR LGPRGLPLLL SGLLLPLCRA FNLDVDSPAE YSGPEGSYFG FAVDFFVPSA
SSRMFLLVGA PKANTTQPGI VEGGQVLKCD WSSTRRCQPI EFDATGNRDY AKDDPLEFKS
HQWFGASVRS KQDKILACAP LYHWRTEMKQ EREPVGTCFL QDGTKTVEYA PCRSQDIDAD
GQGFCQGGFS IDFTKADRVL LGGPGSFYWQ GQLISDQVAE IVSKYDPNVY SIKYNNQLAT
RTAQAIFDDS YLGYSVAVGD FNGDGIDDFV SGVPRAARTL GMVYIYDGKN MSSLYNFTGE
QMAAYFGFSV AATDINGDDY ADVFIGAPLF MDRGSDGKLQ EVGQVSVSLQ RASGDFQTTK
LNGFEVFARF GSAIAPLGDL DQDGFNDIAI AAPYGGEDKK GIVYIFNGRS TGLNAVPSQI
LEGQWAARSM PPSFGYSMKG ATDIDKNGYP DLIVGAFGVD RAILYRARPV ITVNAGLEVY
PSILNQDNKT CSLPGTALKV SCFNVRFCLK ADGKGVLPRK LNFQVELLLD KLKQKGAIRR
ALFLYSRSPS HSKNMTISRG GLMQCEELIA YLRDESEFRD KLTPITIFME YRLDYRTAAD
TTGLQPILNQ FTPANISRQA HILLDCGEDN VCKPKLEVSV DSDQKKIYIG DDNPLTLIVK
AQNQGEGAYE AELIVSIPLQ ADFIGVVRNN EALARLSCAF KTENQTRQVV CDLGNPMKAG
TQLLAGLRFS VHQQSEMDTS VKFDLQIQSS NLFDKVSPVV SHKVDLAVLA AVEIRGVSSP
DHVFLPIPNW EHKENPETEE DVGPVVQHIY ELRNNGPSSF SKAMLHLQWP YKYNNNTLLY
ILHYDIDGPM NCTSDMEINP LRIKISSLQT TEKNDTVAGQ GERDHLITKR DLALSEGDIH
TLGCGVAQCL KIVCQVGRLD RGKSAILYVK SLLWTETFMN KENQNHSYSL KSSASFNVIE
FPYKNLPIED ITNSTLVTTN VTWGIQPAPM PVPVWVIILA VLAGLLLLAV LVFVMYRMGF
FKRVRPPQEE QEREQLQPHE NGEGNSET


Related products :

Catalog number Product name Quantity
20-783-73399 MOUSE ANTI HUMAN INTEGRIN ALPHA V BETA 5 - Vitronectin receptor subunit alpha; CD51 antigen Monoclonal 0.1 mg
20-272-191997 Integrin alpha M - Mouse monoclonal [ICRF 44] to Integrin alpha M; Cell surface glycoprotein MAC-1 alpha subunit; CR-3 alpha chain; Leukocyte adhesion receptor MO1; Neutrophil adherence receptor; CD11 0.2 mg
ITGAX ITGAV Gene integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51)
20-272-191998 Integrin alpha M ( FITC ) - Mouse monoclonal [FITC.ICRF44] to Integrin alpha M ( FITC ); Cell surface glycoprotein MAC-1 alpha subunit; CR-3 alpha chain; Leukocyte adhesion receptor MO1; Neutrophil ad 0.1 mg
CSB-EL011877MO Mouse integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) (ITGAV) ELISA kit, Species Mouse, Sample Type serum, plasma 96T
CSB-EL011877CH Chicken integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) (ITGAV) ELISA kit, Species Chicken, Sample Type serum, plasma 96T
CSB-EL011877HU Human integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) (ITGAV) ELISA kit, Species Human, Sample Type serum, plasma 96T
CSB-EL011877BO Bovine integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) (ITGAV) ELISA kit, Species Bovine, Sample Type serum, plasma 96T
20-783-72298 MOUSE ANTI HUMAN CD11b - INTEGRIN ALPHA M CHAIN. MAC-1; Cell surface glycoprotein MAC-1 subunit alpha; CR-3 alpha chain; Leukocyte adhesion receptor MO1; Neutrophil adherence receptor; CD11b antigen M 0.2 mg
20-783-72303 MOUSE ANTI HUMAN CD11b - INTEGRIN ALPHA M CHAIN. MAC-1; Cell surface glycoprotein MAC-1 subunit alpha; CR-3 alpha chain; Leukocyte adhesion receptor MO1; Neutrophil adherence receptor; CD11b antigen M 0.02 mg
20-783-72301 MOUSE ANTI HUMAN CD11b - INTEGRIN ALPHA M CHAIN. MAC-1; Cell surface glycoprotein MAC-1 subunit alpha; CR-3 alpha chain; Leukocyte adhesion receptor MO1; Neutrophil adherence receptor; CD11b antigen M 0.1 mg
U0271b CLIA Bos taurus,Bovine,Integrin alpha-V,ITGAV,Vitronectin receptor subunit alpha 96T
E0271b ELISA Bos taurus,Bovine,Integrin alpha-V,ITGAV,Vitronectin receptor subunit alpha 96T
U0271m CLIA Integrin alpha-V,Itgav,Mouse,Mus musculus,Vitronectin receptor subunit alpha 96T
E0271b ELISA kit Bos taurus,Bovine,Integrin alpha-V,ITGAV,Vitronectin receptor subunit alpha 96T
E0271m ELISA kit Integrin alpha-V,Itgav,Mouse,Mus musculus,Vitronectin receptor subunit alpha 96T
E0271m ELISA Integrin alpha-V,Itgav,Mouse,Mus musculus,Vitronectin receptor subunit alpha 96T
20-783-72304 MOUSE ANTI HUMAN CD11b Azide Free - INTEGRIN ALPHA M CHAIN. MAC-1; Cell surface glycoprotein MAC-1 subunit alpha; CR-3 alpha chain; Leukocyte adhesion receptor MO1; Neutrophil adherence receptor; CD11 1 mg
E0271h ELISA Homo sapiens,Human,Integrin alpha-V,ITGAV,MSK8,Vitronectin receptor subunit alpha,VNRA 96T
U0271h CLIA Homo sapiens,Human,Integrin alpha-V,ITGAV,MSK8,Vitronectin receptor subunit alpha,VNRA 96T
E0271h ELISA kit Homo sapiens,Human,Integrin alpha-V,ITGAV,MSK8,Vitronectin receptor subunit alpha,VNRA 96T
E1685m ELISA CD11 antigen-like family member B,Cell surface glycoprotein MAC-1 subunit alpha,CR-3 alpha chain,Integrin alpha-M,Itgam,Leukocyte adhesion receptor MO1,Mouse,Mus musculus 96T
E1685m ELISA kit CD11 antigen-like family member B,Cell surface glycoprotein MAC-1 subunit alpha,CR-3 alpha chain,Integrin alpha-M,Itgam,Leukocyte adhesion receptor MO1,Mouse,Mus musculus 96T
U1685m CLIA CD11 antigen-like family member B,Cell surface glycoprotein MAC-1 subunit alpha,CR-3 alpha chain,Integrin alpha-M,Itgam,Leukocyte adhesion receptor MO1,Mouse,Mus musculus 96T
20-783-72299 MOUSE ANTI HUMAN CD11b Biotin - INTEGRIN ALPHA M CHAIN. MAC-1; Cell surface glycoprotein MAC-1 subunit alpha; CR-3 alpha chain; Leukocyte adhesion receptor MO1; Neutrophil adherence receptor; CD11b an 0.1 mg
Pathways :
WP1614: 1- and 2-Methylnaphthalene degradation
WP1963: The effect of Glucocorticoids on target gene expression
WP566: canonical wnt - zebrafish
WP1655: Geraniol degradation
WP1566: Citrate cycle (TCA cycle)
WP1225: estrogen signalling
WP32: Translation Factors
WP2359: Parkin-Ubiquitin Proteasomal System pathway
WP1120: Ovarian Infertility Genes
WP246: TNF-alpha NF-kB Signaling Pathway
WP219: Cytoplasmic tRNA Synthetases
WP433: tRNA Synthetases
WP811: TNF-alpha NF-kB Signaling Pathway
WP1531: Vitamin D synthesis
WP273: Ovarian Infertility Genes
WP1340: Ovarian Infertility Genes
WP1047: TNF-alpha NF-kB Signaling Pathway
WP231: TNF alpha Signaling Pathway
WP1584: Type II diabetes mellitus
WP1224: EBV LMP1 signaling
WP773: Ovarian Infertility Genes
WP1369: TNF-alpha NF-kB Signaling Pathway
WP244: Alpha 6 Beta 4 signaling pathway
WP2100: AhR pathway
WP215: noncanonical wnt pathway

Related Genes :
[ITGAV MSK8 VNRA VTNR] Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]
[Itgav] Integrin alpha-V (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]
[ITGAV] Integrin alpha-V (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]
[ITGA2B GP2B ITGAB] Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]
[ITGA6] Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)]
[Itga6] Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain]
[if CG9623] Integrin alpha-PS2 (Position-specific antigen subunit alpha-2) (Protein inflated) [Cleaved into: Integrin alpha-PS2 heavy chain; Integrin alpha-PS2 light chain]
[scb alphaPS3 Vol CG8095] Integrin alpha-PS3 (Position-specific antigen subunit alpha-3) (Protein scab) (Protein volado) [Cleaved into: Integrin alpha-PS3 heavy chain; Integrin alpha-PS3 light chain]
[ITGA7 UNQ406/PRO768] Integrin alpha-7 [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form]
[ITGAV] Integrin alpha-V (Vitronectin receptor subunit alpha) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]
[Itga7] Integrin alpha-7 [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain]
[ITGA6] Integrin alpha-6 (VLA-6) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain]
[ITGAM CD11B CR3A] Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b)
[ITGAL CD11A] Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a)
[ITGA4 CD49D] Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d)
[Itga4] Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (Lymphocyte Peyer patch adhesion molecules subunit alpha) (LPAM subunit alpha) (VLA-4 subunit alpha) (CD antigen CD49d)
[ITGA2 CD49B] Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b)
[ITGB1] Integrin beta-1 (Fibronectin receptor subunit beta) (Integrin subunit beta-1) (VLA-4 subunit beta) (CD antigen CD29)
[Itgb1] Integrin beta-1 (Fibronectin receptor subunit beta) (VLA-4 subunit beta) (CD antigen CD29)
[ITGB1 FNRB MDF2 MSK12] Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)
[ITGB1] Integrin beta-1 (Fibronectin receptor subunit beta) (VLA-4 subunit beta) (CD antigen CD29)
[Itgb1] Integrin beta-1 (Beta oligodendroglia) (Beta OL) (Fibronectin receptor subunit beta) (VLA-4 subunit beta) (CD antigen CD29)
[ITGB1] Integrin beta-1 (Fibronectin receptor subunit beta) (VLA-4 subunit beta) (CD antigen CD29)
[ITGB1] Integrin beta-1 (Fibronectin receptor subunit beta) (VLA-4 subunit beta) (CD antigen CD29)
[ITGB1] Integrin beta-1 (Fibronectin receptor subunit beta) (VLA-4 subunit beta) (CD antigen CD29)
[ITGB1] Integrin beta-1 (Fibronectin receptor subunit beta) (VLA-4 subunit beta) (CD antigen CD29)
[iaaA spt ybiK b0828 JW0812] Isoaspartyl peptidase (EC 3.4.19.5) (Beta-aspartyl-peptidase) (EcAIII) (Isoaspartyl dipeptidase) [Cleaved into: Isoaspartyl peptidase subunit alpha; Isoaspartyl peptidase subunit beta]
[ITGA8] Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain]
[ITGB1] Integrin beta-1 (CSAT antigen) (JG22 antigen) (RGD-receptor)
[ITGB3 GP3A] Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61)

Bibliography :